Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic
- PMID: 17947294
- DOI: 10.1093/hmg/ddm311
Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic
Abstract
Expanded polyglutamine (polyQ) repeats cause neurodegenerative disorders, but their cytotoxic structures remain to be elucidated. Although soluble polyQ oligomers have been proposed as a cytotoxic structure, the cytotoxicity of soluble polyQ oligomers, not inclusion bodies (IBs), has not been proven in living cells. To clarify the cytotoxicity of soluble polyQ oligomers, we carried our fluorescence resonance energy transfer (FRET) confocal microscopy and distinguished oligomers from monomers and IBs in a single living cell. FRET signals were detected when donor and acceptor fluorescent proteins were attached to the same side, not the opposite side, of polyQ repeats, which agrees with a parallel beta-sheet or a head-to-tail cylindrical beta-sheet model. These FRET signals disappeared in semi-intact cells, indicating that these polyQ oligomers are soluble. PolyQ monomers assembled into soluble oligomers in a length-dependent manner, which was followed by the formation of IBs. Notably, survival assay of neuronally differentiated cells revealed that cells with soluble oligomers died faster than those with IBs or monomers. These results indicate that a length-dependent formation of oligomers is an essential mechanism underlying neurodegeneration in polyQ-mediated disorders.
Similar articles
-
Soluble Oligomers of PolyQ-Expanded Huntingtin Target a Multiplicity of Key Cellular Factors.Mol Cell. 2016 Sep 15;63(6):951-64. doi: 10.1016/j.molcel.2016.07.022. Epub 2016 Aug 25. Mol Cell. 2016. PMID: 27570076
-
Formation and toxicity of soluble polyglutamine oligomers in living cells.PLoS One. 2010 Dec 28;5(12):e15245. doi: 10.1371/journal.pone.0015245. PLoS One. 2010. PMID: 21209946 Free PMC article.
-
Intracellular aggregation of polypeptides with expanded polyglutamine domain is stimulated by stress-activated kinase MEKK1.J Cell Biol. 2001 May 14;153(4):851-64. doi: 10.1083/jcb.153.4.851. J Cell Biol. 2001. PMID: 11352944 Free PMC article.
-
[Molecular mechanism for spinocerebellar ataxias].Rinsho Shinkeigaku. 2009 Jan;49(1):1-8. doi: 10.5692/clinicalneurol.49.1. Rinsho Shinkeigaku. 2009. PMID: 19227889 Review. Japanese.
-
Conformational changes and aggregation of expanded polyglutamine proteins as therapeutic targets of the polyglutamine diseases: exposed beta-sheet hypothesis.Curr Pharm Des. 2008;14(30):3267-79. doi: 10.2174/138161208786404164. Curr Pharm Des. 2008. PMID: 19075705 Review.
Cited by
-
Protein aggregates in Huntington's disease.Exp Neurol. 2012 Nov;238(1):1-11. doi: 10.1016/j.expneurol.2011.12.013. Epub 2011 Dec 19. Exp Neurol. 2012. PMID: 22200539 Free PMC article. Review.
-
Inhibition of protein misfolding/aggregation using polyglutamine binding peptide QBP1 as a therapy for the polyglutamine diseases.Neurotherapeutics. 2013 Jul;10(3):440-6. doi: 10.1007/s13311-013-0184-7. Neurotherapeutics. 2013. PMID: 23504628 Free PMC article. Review.
-
Elongation kinetics of polyglutamine peptide fibrils: a quartz crystal microbalance with dissipation study.J Mol Biol. 2012 Aug 10;421(2-3):329-47. doi: 10.1016/j.jmb.2012.03.017. Epub 2012 Mar 26. J Mol Biol. 2012. PMID: 22459263 Free PMC article.
-
Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington's disease.J Neurosci. 2009 Oct 28;29(43):13589-602. doi: 10.1523/JNEUROSCI.4286-09.2009. J Neurosci. 2009. PMID: 19864571 Free PMC article.
-
A common motif targets huntingtin and the androgen receptor to the proteasome.J Biol Chem. 2008 Aug 29;283(35):23950-5. doi: 10.1074/jbc.M800467200. Epub 2008 Jun 27. J Biol Chem. 2008. PMID: 18586675 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
